The aim of our research was to evaluate efficiency of medicine
Cholisal in complex treatment of
periodontitis. During the research 36 patients with
periodontitis (from 18 to 36 years old) were examined and treated. The patients were divided into 3 groups according to severity of
periodontitis. Each group included 12 patients. For studying the efficiency of treatment both objective and subjective data was used. In case of mild severity of disease clinical indices were: HI=2,1+/-0,75; Ghi=1,4+/-0,67; Gi=1,7+/-0,78, PI=0,8+/-0,34. In case of moderate severity of disease clinical indices were: HI=2,57+/-1,02; GHI=2,18+/-0,81; GI=1,95+/-0,8, PI=3,9+/-1,1. In case of severe disease - HI=3,9+/-1,25, GHI=2,5+/-0,8, GI=2,9+/-1,2, PI=7,8+/-1,62. Clinical study has shown that
Cholisal enables successful treatment of
periodontitis. It has prolonged, antiinflamatory,
deodorant and
analgesic effect. Our investigation revealed that xolisale can be recommended in complex treatment of
periodontal disease.